Initial Treatment for Essential Tremor
Propranolol (80-240 mg/day) or primidone should be initiated as first-line treatment for essential tremor when symptoms interfere with function or quality of life. 1, 2, 3
First-Line Medication Selection
Propranolol as Primary Choice
- Propranolol is the most established first-line agent, demonstrating efficacy in up to 70% of patients and having over 40 years of clinical use 1, 3
- Dosing range: 80-240 mg/day 1, 2
- Provides dual benefit in patients with concurrent hypertension 1
Primidone as Alternative First-Line
- Primidone is equally effective as propranolol and recommended as a co-first-line option by the American Academy of Neurology 1, 3
- Critical timing consideration: Clinical benefits may not appear for 2-3 months, requiring an adequate trial period before declaring treatment failure 1, 3
- Therapeutic benefit can occur even when derived phenobarbital levels remain subtherapeutic, confirming primidone itself has anti-tremor properties 1
Contraindications and Selection Algorithm
When to AVOID Propranolol
Do not use propranolol in patients with: 1, 2, 3
- Chronic obstructive pulmonary disease
- Bradycardia
- Congestive heart failure
Common Adverse Effects of Beta-Blockers
- Fatigue and depression
- Dizziness and hypotension (particularly problematic in elderly patients with gait instability) 3
- Exercise intolerance and sleep disorders
- Cold extremities and bronchospasm
Primidone-Specific Warnings
- Women of childbearing age require counseling about teratogenic risks (neural tube defects) 1, 3
- Behavioral disturbances, irritability, and sleep disturbances can occur at higher doses 1
Treatment Initiation Criteria
Only initiate medication when tremor interferes with function or quality of life 1, 2, 3—not all essential tremor requires pharmacological treatment.
Alternative Beta-Blockers if Propranolol Not Tolerated
If propranolol causes adverse effects, consider: 1, 2
- Nadolol: 40-320 mg daily
- Metoprolol: 25-100 mg extended release daily or twice daily
- Timolol: 20-30 mg/day
- Atenolol (limited evidence for moderate effect)
Second-Line Options
If first-line agents fail or are contraindicated:
- Gabapentin has limited evidence for moderate efficacy 1, 2
- Combination therapy with propranolol plus primidone can be attempted 4
When to Consider Surgical Intervention
Surgical options (deep brain stimulation or MRgFUS thalamotomy) should be considered when: 1, 2, 3
- Medications fail due to lack of efficacy at maximum doses
- Dose-limiting side effects occur
- Medical contraindications exist
- Occupational limitations persist despite optimal medical therapy
MRgFUS thalamotomy shows sustained tremor improvement of 56% at 4 years with lower complication rates (4.4%) compared to radiofrequency thalamotomy (11.8%) and DBS (21.1%) 1, 2